Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants.
作者信息
Kataoka Naoya, Imamura Teruhiko
机构信息
Second Department of Internal Medicine, University of Toyama, Toyama, Japan.
出版信息
Clin Cardiol. 2023 Nov;46(11):1458. doi: 10.1002/clc.24100. Epub 2023 Aug 15.
Abstract
摘要
相似文献
1
Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants.直接口服抗凝剂时代与口服抗凝剂处方相关的因素。
Clin Cardiol. 2023 Nov;46(11):1458. doi: 10.1002/clc.24100. Epub 2023 Aug 15.
2
Prescription of oral anticoagulants and antiplatelets for stroke prophylaxis in atrial fibrillation: nationwide time series ecological analysis.心房颤动患者预防卒中的口服抗凝药和抗血小板药物处方：全国时间序列生态分析
Europace. 2020 Sep 1;22(9):1311-1319. doi: 10.1093/europace/euaa126.
3
Impact of prescription patterns of antithrombotic treatment on atrial fibrillation-related ischemic stroke.抗血栓治疗方案对房颤相关缺血性卒中的影响。
Curr Med Res Opin. 2021 Mar;37(3):357-365. doi: 10.1080/03007995.2020.1865892. Epub 2021 Jan 19.
4
Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation.在新发和现患房颤患者中，肾小球滤过率（GFR）各范围下直接口服抗凝剂的风险和获益。
Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1144-1152. doi: 10.2215/CJN.13811217. Epub 2018 Jul 12.
5
[ANMCO Position paper: Prescription appropriateness of direct oral anticoagulants for stroke and systemic thromboembolis with non-valvular atrial fibrillation].[意大利心脏病学国家协会立场文件：非瓣膜性心房颤动患者预防卒中及全身性血栓栓塞的直接口服抗凝剂的处方适宜性]
G Ital Cardiol (Rome). 2021 Dec;22(12):1024-1033. doi: 10.1714/3698.36882.
6
Association of stroke and bleed events in non-valvular atrial fibrillation patients with direct oral anticoagulant prescriptions in NHS England between 2013 and 2016.2013 年至 2016 年期间，英国国民保健制度中服用直接口服抗凝剂的非瓣膜性心房颤动患者中风和出血事件的相关性。
PLoS One. 2019 Jun 24;14(6):e0218878. doi: 10.1371/journal.pone.0218878. eCollection 2019.
7
Unequal prescription of anticoagulants among females and males with atrial fibrillation and similar stroke risk: Should we omit sex category from the CHADS-VASc score?心房颤动且卒中风险相似的女性和男性在抗凝药物处方上存在差异：我们是否应在CHADS-VASc评分中忽略性别分类？
Heart Rhythm. 2022 May;19(5):860-861. doi: 10.1016/j.hrthm.2022.01.014. Epub 2022 Jan 13.
8
Selection of Oral Anticoagulants in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation.非瓣膜性心房颤动缺血性卒中患者口服抗凝剂的选择
J Stroke Cerebrovasc Dis. 2018 Oct;27(10):2627-2631. doi: 10.1016/j.jstrokecerebrovasdis.2018.05.036. Epub 2018 Jun 30.
9
Factors associated with oral anticoagulant prescription status among patients with a new diagnosis of atrial fibrillation.与新诊断为心房颤动的患者口服抗凝药物处方状况相关的因素。
Clin Cardiol. 2023 Aug;46(8):937-941. doi: 10.1002/clc.24077. Epub 2023 Jul 4.
10
[Restraints to anticoagulation prescription in atrial fibrillation and attitude towards the new oral anticoagulants].[心房颤动抗凝治疗的限制因素及对新型口服抗凝药的态度]
Acta Med Port. 2013 Mar-Apr;26(2):127-32. Epub 2013 May 31.
本文引用的文献
1
Factors associated with oral anticoagulant prescription status among patients with a new diagnosis of atrial fibrillation.与新诊断为心房颤动的患者口服抗凝药物处方状况相关的因素。
Clin Cardiol. 2023 Aug;46(8):937-941. doi: 10.1002/clc.24077. Epub 2023 Jul 4.
2
Population Trends in All-Cause Mortality and Cause Specific-Death With Incident Atrial Fibrillation.人口死因死亡率与特定病因死亡率趋势：与新发心房颤动的关系。
J Am Heart Assoc. 2020 Oct 20;9(19):e016810. doi: 10.1161/JAHA.120.016810. Epub 2020 Sep 13.
3
Stroke and thromboembolism prevention in atrial fibrillation.心房颤动的卒中预防和血栓栓塞预防。
Heart. 2020 Jan;106(1):10-17. doi: 10.1136/heartjnl-2019-314898. Epub 2019 Sep 18.
4
Percutaneous left atrial appendage closure: procedural techniques and outcomes.经皮左心耳封堵：操作技术与结果。
JACC Cardiovasc Interv. 2014 Nov;7(11):1205-20. doi: 10.1016/j.jcin.2014.05.026. Epub 2014 Nov 17.
Zotero 插件